In recent months, Johnson & Johnson has lost three consecutive class action lawsuits over marketing tactics of its controversial – yet highly profitable – antipsychotic medication Risperdal (generic: risperidone). In September 2012, the company settled an individual Risperdal lawsuit filed on behalf of a young man who developed female breasts after being treated with the drug for a period of five years. If you’ve been injured by Risperdal side effects, it’s important to understand that you are not alone, and that Risperdal lawyers are now filing lawsuits in courthouses around the country.

Free Risperdal Lawsuit Evaluation: If you or a loved one has been injured by Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

What’s the problem?

Manufactured and marketed by Janssen Pharmaceuticals (a subsidiary of healthcare giant Johnson & Johnson), Risperdal was approved by the U.S. Food & Drug Administration (FDA) in 1993 for the treatment of schizophrenia and acute mania, or mixed episodes of bipolar disorders. Risperdal is also commonly prescribed in a so-called ‘off-label’ capacity (for which it was neither tested nor approved by the FDA) for the treatment of behavioral disorders in the elderly such as dementia, attention deficit disorder (ADD) in children, as well as depression, anxiety and autism. And though it has proven to be considerably effective at treating a number of these serious medical conditions, Risperdal has also recently been linked to a large number of serious, potentially life-threatening side effects.

2013 Risperdal Settlement

On November 4, 2013, Johnson & Johnson agreed to resolve criminal and civil investigations into the marketing of Risperdal and other widely-prescribed medications by paying over $2.2 billion, one of the largest penalties ever levied against a company for healthcare fraud. According to the agreement, J&J’s Janssen division will plead guilty to misbranding Risperdal for unapproved uses, as well as for paying kickbacks to physicians and to Omnicare Inc., the largest pharmacy for nursing homes. Click here to learn more.

Risperdal Side Effects

Risperdal is associated with the following adverse health complications:

Gynecomastia

Production of prolactin

Pituitary tumors

Tardive Dyskinesia

Stroke

Neuroleptic Malignant Syndrome (NMS)

Increased risk of sudden death from heart attack

Diabetes, hyperglycemia and other blood sugar side effects

Weight gain, potentially rapid and extreme

Suicide, suicidal thoughts

Pancreatitis

Bone loss

Cellulitis

Neutropenia

Increased mortality in the elderly with dementia and related psychosis

More moderate side effects linked to Risperdal have been reported to include:

In September 2014, a hearing held in Vermont raised questions about whether doctors were following dosing guidelines when prescribing antipsychotic drugs like Risperdal to children. A recent survey found that doctors in that state followed the American Academy of Child and Adolescent Psychiatry’s guidelines for antipsychotic use about 51% of the time. The same survey found that Vermont’s physicians only followed the FDA’s recommendations on prescribing antipsychotics to pediatric patients about 27% of the time. Click here to learn more.

J&J Settles Landmark Risperdal Gynecomastia Lawsuit on First Day of Trial

In September 2012, a Risperdal gynecomastia lawsuit filed on behalf of 21-year-old Aaron Banks was settled for an undisclosed amount on the opening day of the trial in Philadelphia. According to allegations raised in the complaint, Banks was treated with Risperdal between the ages of nine and 14, and subsequently developed abnormal male breast tissue (a condition known medically as gynecomastia), which led to prolonged psychological trauma. The terms of Banks’ Risperdal lawsuit settlement have not been made public.

Have Risperdal Class Action Lawsuits Been Filed?

Yes. In April 2012, J&J was ordered to pay $1.1 billion over claims by the state of Arkansas that the company hid the health risks associated with Risperdal from the public and medical communities. The verdict marked the pharmaceutical giant’s third straight loss in Risperdal lawsuits filed on the state level regarding the marketing of the drug. Arkansas accused J&J of concealing the side effects of Risperdal, and of misleading the state’s Medicare program, causing it to overpay for Risperdal prescriptions.

Previous Risperdal class action lawsuits filed by the states of Louisiana and South Carolina resulted in fines against J&J of $258 million and $327 million, respectively, as well as a $158 million settlement in Texas. The U.S. Department of Justice (DOJ) has also demanded that J&J pay $1.8 billion to resolve additional complaints filed over Risperdal.

Do I Have a Risperdal Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Risperdal lawsuits. We are handling individual litigation nationwide and currently accepting new Risperdal injury lawsuits in all 50 states.

Free Risperdal Lawsuit Evaluation: Again, if you or a loved one has been injured by Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

Attention Lawyers: Schmidt & Clark, LLP considers a referral from another lawyer to be one of the greatest compliments. Our law firm has built a reputation for success and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please fill out the form below.

Free Confidential Case Evaluation

To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.